Novan Completes Enrollment in B-SIMPLE4 Pivotal Phase 3 Study of SB206 for Treatment of Molluscum Nasdaq:NOVN

Press/Media: Press / Media

PeriodFeb 1 2021

Media coverage

1

Media coverage

  • TitleNovan Completes Enrollment in B-SIMPLE4 Pivotal Phase 3 Study of SB206 for Treatment of Molluscum Nasdaq:NOVN
    Media name/outletMENAFN -Press Releases (English)
    CountryJordan
    Date2/1/21
    PersonsJohn C Browning